Literature DB >> 30326502

Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement.

Susan J Curry1, Alex H Krist2,3, Douglas K Owens4,5, Michael J Barry6, Aaron B Caughey7, Karina W Davidson8, Chyke A Doubeni9, John W Epling10, David C Grossman11, Alex R Kemper12, Martha Kubik13, C Seth Landefeld14, Carol M Mangione15, Maureen G Phipps16, Michael Silverstein17, Melissa A Simon18, Chien-Wen Tseng19,20, John B Wong21.   

Abstract

Importance: More than 35% of men and 40% of women in the United States are obese. Obesity is associated with health problems such as increased risk for coronary heart disease, type 2 diabetes, various types of cancer, gallstones, and disability. Obesity is also associated with an increased risk for death, particularly among adults younger than 65 years. Objective: To update the US Preventive Services Task Force (USPSTF) 2012 recommendation on screening for obesity in adults. Evidence Review: The USPSTF reviewed the evidence on interventions (behavioral and pharmacotherapy) for weight loss or weight loss maintenance that can be provided in or referred from a primary care setting. Surgical weight loss interventions and nonsurgical weight loss devices (eg, gastric balloons) are considered to be outside the scope of the primary care setting. Findings: The USPSTF found adequate evidence that intensive, multicomponent behavioral interventions in adults with obesity can lead to clinically significant improvements in weight status and reduce the incidence of type 2 diabetes among adults with obesity and elevated plasma glucose levels; these interventions are of moderate benefit. The USPSTF found adequate evidence that behavior-based weight loss maintenance interventions are of moderate benefit. The USPSTF found adequate evidence that the harms of intensive, multicomponent behavioral interventions (including weight loss maintenance interventions) in adults with obesity are small to none. Therefore, the USPSTF concludes with moderate certainty that offering or referring adults with obesity to intensive behavioral interventions or behavior-based weight loss maintenance interventions has a moderate net benefit. Conclusions and Recommendation: The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral interventions. (B recommendation).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30326502     DOI: 10.1001/jama.2018.13022

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  94 in total

1.  Protocol for a cluster-randomized controlled trial of a technology-assisted health coaching intervention for weight management in primary care: The GEM (goals for eating and moving) study.

Authors:  Sandra Wittleder; Adefunke Ajenikoko; Dylaney Bouwman; Yixin Fang; M Diane McKee; Paul Meissner; Stephanie L Orstad; Colin D Rehm; Scott E Sherman; Shea Smith; Victoria Sweat; Lorena Velastegui; Judith Wylie-Rosett; Melanie Jay
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

Review 2.  Primary Care Interventions for Obesity: Review of the Evidence.

Authors:  Jena Shaw Tronieri; Thomas A Wadden; Ariana M Chao; Adam Gilden Tsai
Journal:  Curr Obes Rep       Date:  2019-06

3.  The Behavioral Medicine Research Council: Its origins, mission, and methods.

Authors:  Kenneth E Freedland
Journal:  Health Psychol       Date:  2019-04       Impact factor: 4.267

Review 4.  Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review.

Authors:  Jeffrey I Mechanick; Michael E Farkouh; Jonathan D Newman; W Timothy Garvey
Journal:  J Am Coll Cardiol       Date:  2020-02-11       Impact factor: 24.094

5.  Proportion of Cancer Cases Attributable to Excess Body Weight by US State, 2011-2015.

Authors:  Farhad Islami; Ann Goding Sauer; Susan M Gapstur; Ahmedin Jemal
Journal:  JAMA Oncol       Date:  2019-03-01       Impact factor: 31.777

6.  Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial.

Authors:  Thomas A Wadden; Olivia A Walsh; Robert I Berkowitz; Ariana M Chao; Naji Alamuddin; Kathryn Gruber; Sharon Leonard; Kimberly Mugler; Zayna Bakizada; Jena Shaw Tronieri
Journal:  Obesity (Silver Spring)       Date:  2018-11-13       Impact factor: 5.002

7.  Uptake of Obesity Intensive Behavioral Treatment Codes in Medicare Beneficiaries, 2012-2015.

Authors:  Shenbagam Dewar; Julie Bynum; John A Batsis
Journal:  J Gen Intern Med       Date:  2019-10-22       Impact factor: 5.128

8.  Effect of an Intervention for Obesity and Depression on Patient-Centered Outcomes: An RCT.

Authors:  Lisa G Rosas; Kristen M J Azar; Nan Lv; Lan Xiao; Jeremy D Goldhaber-Fiebert; Mark B Snowden; Elizabeth M Venditti; Megan M Lewis; Andrea N Goldstein-Piekarski; Jun Ma
Journal:  Am J Prev Med       Date:  2020-02-14       Impact factor: 5.043

Review 9.  A Protocol to Deliver Intensive Behavioral Therapy (IBT) for Obesity in Primary Care Settings: The MODEL-IBT Program.

Authors:  Thomas A Wadden; Adam G Tsai; Jena Shaw Tronieri
Journal:  Obesity (Silver Spring)       Date:  2019-10       Impact factor: 5.002

10.  Group Lifestyle Phone Maintenance for Weight, Health, and Physical Function in Adults Aged 65-80 Years: A Randomized Clinical Trial.

Authors:  Elizabeth M Venditti; Marsha D Marcus; Rachel G Miller; Vincent C Arena; Susan L Greenspan; Bonny Rockette-Wagner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-01-18       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.